Investors

Press Releases

Official announcements, media updates, and the latest news on our commitment to advancing patient care and medical innovation.

Featured Press Release

AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

September 2, 2026 Learn More

Featured Press Release

AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

August 18, 2026 Learn More

Year

Sep 2, 2026 AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

Aug 18, 2026 AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

Event: Aug 12, 2026 Canaccord Genuity 46th Growth Conference

Event: Aug 12, 2026 Investor Webinar Briefing

Aug 9, 2026 AVITA Medical to Host Investor Webinar Briefing

Aug 7, 2026 AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

Aug 6, 2026 AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

Event: Aug 6, 2026 AVITA Medical, Inc. Second Quarter 2026 Earnings Conference Call

Jul 14, 2026 AVITA Medical to Announce Second Quarter 2026 Financial Results

Jun 18, 2026 AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

Event: May 21, 2026 “Armchair” chat with Cary Vance, President and CEO

May 17, 2026 AVITA Medical to Host Investor Webinar Briefing

May 14, 2026 AVITA Medical Reports First Quarter 2026 Financial Results

Apr 30, 2026 AVITA Medical Names Cary Vance as Chief Executive Officer

Apr 29, 2026 AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO

Apr 23, 2026 AVITA Medical to Announce First Quarter 2026 Financial Results

Apr 15, 2026 AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

Apr 14, 2026 AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

Apr 8, 2026 AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

Apr 7, 2026 AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

Feb 23, 2026 AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

Feb 13, 2026 AVITA Medical to Host Investor Webinar Briefing

Feb 12, 2026 AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

Jan 25, 2026 Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies

Jan 13, 2026 AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook

Jan 5, 2026 AVITA Medical Announces Changes to its Board of Directors